Lumexa Imaging Holdings Inc Revenue Growth Rates (LMRI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Lumexa Imaging Holdings Inc   (LMRI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

LMRI's Revenue Growth by Quarter and Year

Lumexa Imaging Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/LMRI/growth
https://api.csimarket.com/api/v1/companies/LMRI/fundamentals
https://api.csimarket.com/api/v1/companies/LMRI/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
LMRI Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 271.97
2nd Quarter June 264.16
1st Quarter March 252.54
FY 788.67





LMRI Revenue third quarter 2026 Y/Y Growth Comment
Lumexa Imaging Holdings Inc achieved in the third quarter 2026, above Company average Revenue improvement of 8.18% year on year, to $ 271.97 millions.

Looking into third quarter 2026 results within Medical Laboratories industry 10 other companies have achieved higher Revenue growth. While Lumexa Imaging Holdings Inc ' s Revenue increase of 8.18% ranks overall at the positon no. 1167 in the third quarter 2026.


LMRI Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 8.18 %
2nd Quarter June 7.82 %
1st Quarter March -
FY   -

Financial Statements
Lumexa Imaging Holdings Inc 's third quarter 2026 Revenue $ 271.97 millions LMRI's Income Statement
Lumexa Imaging Holdings Inc 's third quarter 2025 Revenue $ 251.40 millions Quarterly LMRI's Income Statement


LMRI Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 2.96 %
2nd Quarter June 4.6 %
1st Quarter March -2.47 %
FY (Year on Year)   -


Back to LMRI Growth rate Comparisons >> Back to LMRI Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #11
Healthcare Sector #175
Overall #1167

Revenue Y/Y Growth Statistics
High Average Low
4.6 % 3.61 % 2.61 %
(Jun 30 2026)   (Jun 30 2025)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #11
Healthcare Sector #175
Overall #1167
Revenue Y/Y Growth Statistics
High Average Low
4.6 % 3.61 % 2.61 %
(Jun 30 2026)   (Jun 30 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Lumexa Imaging Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
4.6 % 3.61 % 2.61 %
(Jun 30 2026)  


LMRI's III. Quarter Q/Q Revenue Comment
Lumexa Imaging Holdings Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.96% quarter on quarter, to $ 271.97 millions.

Although the III. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the III. Quarter surge, eclipses the 2.61% growth in the III. Quarter a year ago

Within Medical Laboratories industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Lumexa Imaging Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1167.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #11
Healthcare Sector #175
Overall #1167
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #11
Healthcare Sector #175
Overall #1167
Revenue Q/Q Growth Statistics
High Average Low
4.6 % 3.61 % 2.61 %
(Jun 30 2026)  


LMRI's III. Quarter Q/Q Revenue Comment
Lumexa Imaging Holdings Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.96% quarter on quarter, to $ 271.97 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 2.61% in the III. Quarter a year ago.

Within Medical Laboratories industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Lumexa Imaging Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1167.


Lumexa Imaging Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending 12 Months Ending 12 Months Ending 12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00
Y / Y Revenue Growth (TTM) -
Year on Year Revenue Growth Overall Ranking #
Seqeuential Revenue Change (TTM) -
Seq. Revenue Growth (TTM) Overall Ranking #


Cumulative Revenue growth Comment
In the Mar 31 2026 period, Lumexa Imaging Holdings Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Lumexa Imaging Holdings Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 31 2026 period, Lumexa Imaging Holdings Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Lumexa Imaging Holdings Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LMRI's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Allogene Therapeutics Inc 14.29%$ 14.286 millions
Tandem Diabetes Care Inc 14.26%$ 14.257 millions
Iradimed Corporation14.15%$ 14.154 millions
Apyx Medical Corp14.09%$ 14.093 millions
Incyte Corporation14.00%$ 13.999 millions
Aurinia Pharmaceuticals Inc 13.93%$ 13.926 millions
Indivior Pharmaceuticals Inc 13.74%$ 13.738 millions
Cryoport inc 13.54%$ 13.535 millions
Neuronetics Inc 13.35%$ 13.350 millions
Royalty Pharma Plc13.26%$ 13.263 millions
Evolus Inc 13.23%$ 13.235 millions
Privia Health Group Inc 13.19%$ 13.187 millions
Biocryst Pharmaceuticals Inc 13.11%$ 13.110 millions
U S Physical Therapy Inc12.90%$ 12.898 millions
Maravai Lifesciences Holdings Inc 12.78%$ 12.781 millions
Alphatec Holdings Inc 12.67%$ 12.670 millions
Harmony Biosciences Holdings inc 12.61%$ 12.609 millions
Medicinova Inc 12.35%$ 12.355 millions
Bionano Genomics Inc 12.34%$ 12.339 millions
Viemed Healthcare Inc 12.18%$ 12.180 millions
Ufp Technologies Inc 12.15%$ 12.154 millions
Innovage Holding Corp 12.14%$ 12.135 millions
Vertex Pharmaceuticals Inc11.85%$ 11.845 millions
Sanara Medtech Inc 11.67%$ 11.668 millions
Lemaitre Vascular Inc 11.51%$ 11.508 millions
Pacs Group Inc 11.45%$ 11.454 millions
Ocugen Inc 11.36%$ 11.358 millions
Dexcom Inc 11.26%$ 11.263 millions
Elanco Animal Health Incorporated11.26%$ 11.258 millions
Koru Medical Systems Inc 11.19%$ 11.194 millions


About Lumexa Imaging Holdings Inc Revenue Growth Rates (LMRI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Lumexa Imaging Holdings Inc (CIK 2071288).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-456953
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Lumexa Imaging Holdings Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.